MEDFAR Solutions Cliniques

Based in Canada, MEDFAR Solutions Cliniques specializes in providing an integrated healthcare platform that enhances efficiency and quality of care delivery by connecting healthcare providers, care teams, and patients in a single ecosystem. MEDFAR Solutions Cliniques, founded in 2010 and headquartered in Montreal, Canada, offers a comprehensive electronic medical records (EMR) system. The company has successfully completed three funding deals, with the most recent being a Series C round of CAD 30. 000 mn on April 18, 2023, led by Investment Quebec along with BDC Capital and CIBC Innovation Banking, and supported by returning investor Walter Capital Partners.

This funding round has raised the total amount raised to CAD 30. 000 mn. The core offering of MEDFAR Solutions Cliniques is its integrated healthcare platform, MYLE, which includes a comprehensive electronic medical records (EMR) system. MYLE facilitates streamlined workflows, allowing healthcare professionals to manage patient data, coordinate care, and communicate securely.

It addresses various areas such as chronic disease management, preventive care, and patient engagement, thus empowering patients to actively participate in their health journey. MYLE is utilized by a diverse client base of healthcare professionals and clinics across Canada and the United States, spanning primary care, long-term care facilities, and mental health organizations. MYLE operates on a subscription-based revenue model, providing services to individual healthcare providers and larger medical practices. Clients subscribe on an annual or monthly basis, gaining access to the EMR system along with features like secure messaging and appointment scheduling.

These subscription fees are adaptable based on the practice size and service packages selected, establishing a B2B relationship where clinics and professionals enhance their operational efficiency and patient care capabilities through MYLE's offerings. In April 2023, MEDFAR Solutions Cliniques raised CAD 30. 000 mn in Series C funding, which will be utilized to accelerate its North American expansion and support its M&A strategy. The company is focused on launching new products and aims to penetrate additional markets, targeting specific regions for growth and expansion.